학술논문

Use of molecular beacons and multi-allelic real-time PCR for detection of and discrimination between virulent Bacillus anthracis and other Bacillus isolates
Document Type
Report
Source
Journal of Microbiological Methods. July, 2009, Vol. 78 Issue 1, p45, 9 p.
Subject
Fluorescence
RNA
Biological warfare
Language
English
ISSN
0167-7012
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.mimet.2009.04.005 Byline: Andreas V. Hadjinicolaou (a), Victoria L. Demetriou (a), Johana Hezka (a), Wolfgang Beyer (b), Ted L. Hadfield (c), Leondios G. Kostrikis (a) Keywords: Bacillus anthracis detection; Molecular beacons; Real-time PCR Abstract: The awareness of the threat of Bacillus anthracis, the causative agent of the disease anthrax, as a biowarfare and bioterrorism weapon has revived the development of new technologies for rapid and accurate detection of virulent isolates in environmental and clinical samples. Here we explore the utility of molecular beacon real-time PCR technology for detection of virulent Bacillus anthracis strains. Molecular beacons are nucleic acid probes with high specificity, that act as switches by emitting fluorescence when bound to their nucleotide sequence targets by means of altering their conformation. In this study, five molecular beacons targeting Bacillus anthracis capA, capB, capC, lef, and pag alleles were designed and used in five uniplex assays. Another molecular beacon targeting the Bacillus group chromosomal 16s rRNA allele was designed for use in a duplex assay with an internal PCR amplification control. The molecular beacons were used in a real-time PCR assay for the detection of and differentiation between virulent B. anthracis and other members of the B. cereus group at the molecular level. Various B. anthracis samples as well as other bacterial and human samples were used to demonstrate the sensitivity and specificity of this assay. Use of the molecular beacon real-time PCR technology should accelerate current efforts to swiftly detect B. anthracis strains and its virulence plasmids in clinical and environmental samples and may extend to the development of additional molecular beacon-based assays for the identification of other pathogenic agents or the identification of B. anthracis directly from clinical samples. Author Affiliation: (a) Department of Biological Sciences, University of Cyprus, 75 Kallipoleos Avenue, P.O. Box 20537, 1678, Nicosia, Cyprus (b) University of Hohenheim, Institute of Environmental and Animal Hygiene, Garbenstrasse 70, 70599, Stuttgart BW, Germany (c) Midwest Research Institute, Florida Division, 1470 Treeland Blvd SE, 32909, Palm Bay, Florida, USA Article History: Received 12 March 2009; Revised 10 April 2009; Accepted 14 April 2009